Adolescent context of exposure to prescription opioids and substance use disorder symptoms at age 35: A national longitudinal study

Pain

Volumn 157, Issue 10, 2016, Pages 2173-2178

  McCabe, Sean Esteban ^a   Veliz, Philip ^a   Schulenberg, John E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adolescence; Adulthood; Epidemiology; Longitudinal; Medical use; Nonmedical use; Prescription opioids; Substance use disorder

Indexed keywords

OPIATE; CENTRAL STIMULANT AGENT; COCAINE; CODEINE; DIAMORPHINE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; LYSERGIDE; MORPHINE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PETHIDINE; PSYCHEDELIC AGENT; SEDATIVE AGENT; TRANQUILIZER; NARCOTIC ANALGESIC AGENT;

ADOLESCENCE; ADULT; ALCOHOLISM; ARTICLE; CANNABIS USE; CORRELATIONAL STUDY; DRUG EXPOSURE; DRUG USE; FEMALE; HEALTH SURVEY; HIGH SCHOOL STUDENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY SAMPLE; QUESTIONNAIRE; ADOLESCENT; ADOLESCENT HEALTH; CONTROLLED STUDY; DRUG DEPENDENCE; MEDICAL HISTORY; OUTCOME ASSESSMENT; COHORT ANALYSIS; DRUG MISUSE; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; COHORT STUDIES; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84988930761     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000624     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing, 2013.
2. Bachman JG, O'Malley PM, Schulenberg JE, Johnston LD, Bryant AL, Merline AC. The decline of substance use in young adulthood: changes in social activities, roles, and beliefs. Mahwah: Lawrence Erlbaum Associates, 2002.
3. Bachman JG, Wadsworth KN, O'Malley PM, Johnston LD, Schulenberg JE. Smoking, drinking, and drug use in young adulthood: the impacts of new freedoms and new responsibilities. Mahwah: Lawrence Erlbaum Associates, 1997.
4. Blanco C, Alderson D, Ogburn E, Grant BF, Nunes EV, Hatzenbuehler ML, Hasin DS. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007; 90: 252-60.
5. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315-21.
6. Boyd CJ, Teter CJ, West BT, Morales M, McCabe SE. Non-medical use of prescription analgesics: a three-year national longitudinal study. J Addict Dis. 2009; 28: 232-42.
7. Colliver JD, Kroutil LA, Dai L, Gfroerer JC. Misuse of prescription drugs: data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health (DHHS Publication No. SMA 06-4192, Analytic Series A-28). Rockville: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2006.
8. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64: 566-76.
9. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83: 4-7.
10. Fortuna RJ, Robbins BW, Caiola E, Joynt M, Halterman JS. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010; 126: 1108-16.
11. Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, Pickering RP, Ruan WJ, Huang B, Grant BF. Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions-III. J Stud Alcohol Drugs. 2015; 76: 378-88.
12. Grant BF, Goldstein RB, Tulshi DS, Chou P, Jung J, Zhang H, Pickering RP, Ruan J, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry. 2015; 72: 757-66.
13. Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, Hasin DS. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry. 2016; 73: 39-47.
14. Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 in the United States, 2003-2013. JAMA. 2015; 314: 1468-78.
15. Harford TC, Muthé n BO. The dimensionality of alcohol abuse and dependence: a multivariate analysis of DSM-IV symptom items in the National Longitudinal Survey of Youth. J Stud Alcohol. 2001; 62: 150-7.
16. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007; 64: 830-42.
17. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE, Miech RA. Monitoring the future national survey results on drug use, 1975-2014. In: College students and adults ages 19-55, Vol. 2. Ann Arbor: University of Michigan Institute for Social Research, 2015.
18. Johnston LD, O'Malley PM. Issues of validity and population coverage in student surveys of drug use. NIDA Res Monogr. 1985; 57: 31-54.
19. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and non-medical use of opioids: a ten-year perspective. Pain Physician. 2010; 13: 401-35.
20. McCabe SE, Boyd CJ, Young A. Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2007; 40: 76-83.
21. McCabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent poly-drug use of alcohol and prescription drugs: prevalence, correlates and consequences. J Stud Alcohol. 2006; 67: 529-37.
22. McCabe SE, Schulenberg JE, O'Malley PM, Patrick ME, Kloska DD. Nonmedical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study. Addiction. 2014; 109: 102-10.
23. McCabe SE, West BT, Boyd CJ. Medical use, medical misuse, and nonmedical use of prescription opioids: results from a longitudinal study. PAIN. 2013; 154: 708-13.
24. Deleted in proof
25. McCabe SE, West BT, Cranford JA, Ross-Durow P, Young A, Teter CJ, Boyd CJ. Medical misuse of controlled medications among adolescents. Arch Pediatr Adolesc Med. 2011; 165: 729-35.
26. McCabe SE, West BT, Teter CJ, Boyd CJ. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med. 2012; 166: 797-802.
27. McCabe SE, West BT, Teter CJ, Boyd CJ. Co-ingestion of prescription opioids and other drugs among high school seniors: results from a national study. Drug Alcohol Depend. 2012; 126: 65-70.
28. Merline A, Jager J, Schulenberg J. Adolescent risk factors for adult alcohol use and abuse: stability and change of predictive value across early and middle adulthood. Addiction. 2008; 103(suppl 1): 84-99.
29. Miech RA, Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975-2014. In: Secondary school students, Vol. 1. Ann Arbor: University of Michigan Institute for Social Research, 2015.
30. Miech R, Johnston L, O'Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015; 136: e1169-77.
31. Morral AR, McCaffrey DF, Chien S. Measurement of adolescent drug use. J Psychoactive Drugs. 2003; 35: 301-9.
32. Muhuri PK, Gfroerer JC, Davie C. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Substance Abuse Ment Health Serv Adm 2013.
33. Muthé n BO. Psychometric evaluation of diagnostic criteria: application to a two-dimensional model of alcohol abuse and dependence. Drug Alcohol Depend. 1996; 41: 101-12.
34. Nelson CB, Heath AC, Kessler RC. Temporal progression of alcohol dependence symptoms in the U.S. household population: results from the National Comorbidity Survey. J Consult Clin Psychol. 1998; 66: 474-83.
35. O'Malley PM, Bachman JG, Johnston LD. Reliability and consistency in self-reports of drug use. Int J Addict. 1983; 18: 805-24.
36. Patrick ME, Schulenberg JE, O'Malley PM, Johnston LD, Bachman JG. Adolescents? reported reasons for alcohol and marijuana use as predictors of substance use and problems in adulthood. J Stud Alcohol Drugs. 2011; 72: 106-16.
37. Schulenberg JE, Patrick ME, Kloska DD, Maslowsky J, Maggs JL, O'Malley PM. Substance use disorder in early midlife: A national prospective study on health and well-being correlates and long-Term predictors. Subst Abuse. 2016; 9(suppl 1): 41-57.
38. Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011. National estimates of drug-related emergency department visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville: Substance Abuse and Mental Health Services Administration, 2013.
39. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville: Substance Abuse and Mental Health Services Administration, 2014.
40. West BT, McCabe SE. Alternative approaches for assessing nonresponse bias in longitudinal survey estimates: an application to substance use outcomes among young adults in the U.S. Am J Epidemiol. In press
41. Young AM, Glover N, Havens JR. Nonmedical use of prescription medications among adolescents in the United States: a systematic review. J Adolesc Health. 2012; 51: 6-17.
42. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid nonmedical use and abuse: position statement. Drug Alcohol Depend. 2003; 69: 215-32.